Activation of A2AR triggers intracellular signaling pathways that suppress T cell proliferation, cytokine production, and cytotoxic functions, thereby dampening anti-tumor immunity and facilitating tumor immune evasion (45–48). Here, ADORA2A is linked to neoplasm.